Nucs AI

Company profile

Nucs AI company profile

Nucs AI is an advanced AI platform for medical imaging, starting with PSMA PET/CT and prostate cancer care. The platform delivers fully automated lesion detection, whole-body tumor quantification, disease staging, and treatment-response prediction across complex imaging modalities. Its product suite — DeepPSMA, SelectPSMA, and TrackPSMA — provides a clinical-grade infrastructure that supports clinicians, researchers, OEMs, and pharma partners in building next-generation imaging and therapy workflows. By combining proprietary datasets with high-fidelity multimodal models, Nucs AI enables objective, reproducible insights that help select the right treatment for the right patient at the right time. The platform also automates critical parts of the clinician workflow, reducing burnout and improving consistency in demanding oncology settings. Nucs AI is expanding beyond prostate cancer into broader oncology and advanced imaging applications, becoming the intelligence layer for precision imaging and personalized care.